Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.40 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.40 |
| ▸ | ITGAL | P20701 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2514366 | 1.00 | ECE1 (0.42) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL1096294 | 0.89 | ECE1 (0.43) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL1986931 | 0.84 | ECE1 (0.43) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL1986933 | 0.84 | ECE1 (0.43) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL20521 | 0.84 | CA2 (0.44) | CA2MAPT | |
| SCHEMBL472192 | 0.84 | CA2 (0.44) | CA2MAPT | |
| SCHEMBL4392510 | 0.83 | ECE1 (0.40) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL28372032 | 0.82 | CA2 (0.42) | CA2MAPT | |
| SCHEMBL10801439 | 0.82 | CA2 (0.42) | CA2MAPT | |
| SCHEMBL28623751 | 0.82 | CA2 (0.42) | CA2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5849291-A | Opthalmic non-irritating iodine medicament | SYMBOLLON CORPORATION (US) | 1998-12-15 | — | — | US | claimed |
| US-20260109872-A1 | Ink Jet Ink Composition And Ink Jet Recording Method | SEIKO EPSON CORP (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20250304813-A1 | Treatment Liquid Composition For Ink Jet And Ink Set | SEIKO EPSON CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| US-20250297425-A1 | Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250297119-A1 | Method Of Using Ink, Ink Set, Method Of Producing Ink Jet Ink Composition, And Ink Jet Ink Composition | SEIKO EPSON CORPORATION (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250121611-A1 | Ink Jet Textile Printing Method And Set | SEIKO EPSON CORPORATION (JP) | 2025-04-17 | — | — | US | disclosed |
| EP-4474568-A1 | RECORDING METHOD AND COMPOSITION SET | Seiko Epson Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| EP-4474569-A1 | SET AND INK JET RECORDING METHOD | Seiko Epson Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| US-20240400849-A1 | Set And Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240399742-A1 | Ink Jet Recording Method | SEIKO EPSON CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20210032485-A1 | AQUEOUS INK JET INK COMPOSITION AND AN INK JET RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2021-02-04 | — | — | US | disclosed |
| US-10894412-B2 | Ink jet recording apparatus | SEIKO EPSON CORPORATION | 2021-01-19 | — | — | US | disclosed |
| US-20200061997-A1 | Ink Jet Recording Apparatus | SEIKO EPSON CORPORATION (JP) | 2020-02-27 | — | — | US | disclosed |
| US-20190249025-A1 | TEXTILE PRINTING INK JET INK COMPOSITION SET AND RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2019-08-15 | — | — | US | disclosed |
| US-9637655-B2 | Aqueous pigment dispersion and aqueous ink composition containing the same | SEIKO EPSON CORPORATION (JP) | 2017-05-02 | — | — | US | disclosed |
| CN-103804991-B | Ink jet recording method and record thing | 精工爱普生株式会社 | 2016-08-17 | — | — | CN | disclosed |
| US-20160222242-A1 | AQUEOUS PIGMENT DISPERSION AND AQUEOUS INK COMPOSITION CONTAINING THE SAME | SEIKO EPSON CORP (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334411-B2 | Aqueous pigment dispersion and aqueous ink composition containing the same | SEIKO EPSON CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| US-20150096466-A1 | AQUEOUS PIGMENT DISPERSION AND AQUEOUS INK COMPOSITION CONTAINING THE SAME | SEIKO EPSON CORPORATION (JP) | 2015-04-09 | — | — | US | disclosed |
| US-5759539-A | Method for rapid enzymatic alcohol removal | GEORGIA RESEARCH FOUNDATION, INC. (US) | 1998-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109872-A1 | Ink Jet Ink Composition And Ink Jet Recording Method | COPE, EED, VCL | ECE1 540/4885MEN1 3996/4885KMT2A 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.